Fibroids Clinical Trials
Here are the 0 most popular medical studies for fibroids
Frequently Asked Questions
Introduction to fibroids
What are the top hospitals conducting fibroids research?
When it comes to clinical trials focused on fibroids, hospitals across different locations are making strides in advancing treatment options for this common condition. In Chandler, the local hospital is actively conducting two trials related to fibroids, demonstrating their commitment to finding innovative solutions. Similarly, Canoga Park's hospital is also investing resources into two ongoing fibroid trials with the aim of improving patient outcomes. Hialeah, Lake Worth, and Miami join these efforts with each of their respective hospitals currently engaged in two active clinical trials focused specifically on fibroids. While none of these hospitals have conducted previous studies in this area as recorded by available data, their dedication towards researching and addressing fibroids showcases a collective determination within the medical community to benefit patients grappling with this condition.
Fibroids are non-cancerous growths that develop in or around the uterus and affect millions of women worldwide. They can vary widely in size and symptoms, ranging from heavy menstrual bleeding and pelvic pain to complications during pregnancy. By conducting these clinical trials dedicated solely to understanding fibroids better and exploring new potential treatments or interventions for patients suffering from them indicate an increasing recognition within medical communities that more research is needed on this prevalent condition affecting women's health.
These hospitals' involvement highlights not only their commitment but also encourages collaborative efforts among healthcare professionals striving towards enhancing knowledge about fibroids while offering hope for those affected by providing access to cutting-edge therapies through participation in ongoing clinical trials. Although there may be no historical records yet regarding completed research projects specifically targeting fibroids at present; however backing such investigations still indicates a promising development which ultimately contributes significantly toward discovering effective treatments for individuals struggling with this often-overlooked ailment impacting countless lives globally
Which are the best cities for fibroids clinical trials?
When it comes to fibroids clinical trials, several cities emerge as leaders in research and development. Miami, Florida boasts 10 active trials focusing on treatments such as Saroglitazar Magnesium 2 mg and Elagolix. Atlanta, Georgia follows closely with 9 ongoing studies centered around interventions like Elagolix and Vilaprisan (BAY1002670). Tucson, Arizona showcases 8 active trials exploring treatment options including Relugolix Combination Therapy and Saroglitazar Magnesium 2 mg. Other notable cities include Houston, Texas with 7 trials underway studying Vilaprisan (BAY1002670) among others, and San Diego, California with a total of 6 active trials investigating various interventions for fibroids. These cities offer individuals afflicted by fibroids access to cutting-edge clinical research that may bring about advancements in care and improved outcomes.
Which are the top treatments for fibroids being explored in clinical trials?
Fibroids, a common condition among women, are currently the subject of various clinical trials exploring potential treatments. One notable contender is Saroglitazar Magnesium 2 mg—a promising drug being tested in one ongoing trial dedicated to fibroids. While its presence may be relatively recent since its first listing in 2021, it holds immense potential for advancing treatment options and improving the lives of individuals affected by this condition. As researchers delve deeper into these trials, they continue to pave the way towards innovative solutions for managing fibroids effectively.
What are the most recent clinical trials for fibroids?
Exciting advancements in fibroid treatment are emerging from recent clinical trials, offering hope and potential breakthroughs for those affected by this condition. One notable trial evaluated the efficacy of a relugolix combination tablet in treating fibroids, reaching Phase 3 and becoming available on 9/14/2023. Additionally, a Phase 3 trial investigated the use of green tea extract as a potential therapy for fibroids with promising results since it became available on 1/5/2023. Another noteworthy study reached Phase 2 and explored Cohort 1's response to an innovative treatment approach for fibroids since its availability on 9/8/2022. As we eagerly await further developments, these trials pave the way towards improved management options for individuals grappling with fibroids.
What fibroids clinical trials were recently completed?
Several recent clinical trials have made significant progress in the field of fibroids. In May 2022, Vertex Pharmaceuticals Incorporated completed a trial for ELX/TEZ/IVA, followed by another completion of the same therapy in January 2022. Nabriva Therapeutics AG also concluded their study on Lefamulin in March 2022. Various other trials were carried out, including ones sponsored by Insmed Incorporated (Brensocatib) and Stanford University (Empagliflozin 10 MG), both completed in November 2021. These advancements showcase ongoing efforts to find innovative treatments for fibroids and offer hope to patients affected by this condition.